Opioid Receptor Polymorphism A118G Associated with Clinical Severity in a Drug Overdose Population

Journal of Medical Toxicology

Volumn 9, Issue 2, 2013, Pages 148-154

  Manini, A F ^a   Jacobs, M M ^b   Vlahov, D ^c   Hurd, Y L ^b  

^a ELMHURST HOSPITAL CENTER   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Addiction; Cardiac arrest; Opioid receptor; Overdose; Polymorphism

Indexed keywords

ADRENERGIC RECEPTOR STIMULATING AGENT; ALCOHOL; ANTIDEPRESSANT AGENT; BENZODIAZEPINE; DNA; METHADONE; MU OPIATE RECEPTOR; NEUROLEPTIC AGENT; OPIATE;

ADULT; ALTERNATIVE RNA SPLICING; ARTICLE; ARTIFICIAL VENTILATION; BLOOD SAMPLING; COHORT ANALYSIS; CONTROLLED STUDY; DEMOGRAPHY; DISEASE SEVERITY; DNA PURIFICATION; DRUG OVERDOSE; EMERGENCY PATIENT; EMERGENCY WARD; FEMALE; GENE AMPLIFICATION; GENE FREQUENCY; GENETIC VARIABILITY; GENOTYPE; HEART ARREST; HUMAN; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; OPIATE ADDICTION; OUTCOME ASSESSMENT; PAIN; PROSPECTIVE STUDY; RECEPTOR GENE; RESPIRATORY ARREST; SINGLE NUCLEOTIDE POLYMORPHISM; TEACHING HOSPITAL;

ADULT; ALTERNATIVE SPLICING; AMINO ACID SUBSTITUTION; BENZODIAZEPINES; COHORT STUDIES; DRUG OVERDOSE; FEMALE; FOLLOW-UP STUDIES; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HEART ARREST; HUMANS; MALE; NARCOTICS; PILOT PROJECTS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROSPECTIVE STUDIES; RECEPTORS, OPIOID, MU; RESPIRATORY INSUFFICIENCY; SEVERITY OF ILLNESS INDEX; SYMPATHOMIMETICS; UNITED STATES;

EID: 84878110916     PISSN: 15569039     EISSN: 19376995     Source Type: Journal    
DOI: 10.1007/s13181-012-0286-3     Document Type: Article

References (31)

1. Warner M, Chen LH, Makuc DM, Anderson RN, Miniño AM (2011) Drug poisoning deaths in the United States, 1980-2008. NCHS data brief, no 81. Hyattsville, MD: National Center for Health Statistics.
2. Centers for Disease Control and Prevention. WONDER [Online]. (2007) Centers for Disease Control and Prevention. Available at: http://wonder. cdc. gov. Accessed June 1, 2012.
3. Paulozzi LJ, Budnitz DS, Xi Y (2006) Increasing deaths from opioid analgesics in the United States. Pharmacoepidemiol Drug Saf 15: 618-627.
4. Hall AJ, Logan JE, Toblin RL et al (2008) Patterns of abuse among unintentional pharmaceutical overdose fatalities. JAMA 300: 2613-2620.
5. Paulozzi LJ, Jones CM, Mack KA, et al (2011) Vital Signs: overdoses of prescription opioid pain relievers - United States, 1999-2008. MMWR Vol 60 No 43.
6. Polomano RC, Gelnett CM, Heffner SM et al (2001) Evidence for opioid variability: Part 1. A biological perspective. Semin Perioper Nurs 10: 3-16.
7. Polomano RC, Heffner SM, Reck DL, Gelnett CM, French D (2001) Evidence for opioid variability: Part 2. Psychosocial influences. Semin Perioper Nurs 10: 159-166.
8. Bond C, LaForge KS, Tian M et al (1998) Single-nucleotide polymorphism in the human mu opioid receptor gene alters beta-endorphin binding and activity: possible implications for opiate addiction. Proc Natl Acad Sci 95: 9608-9613.
9. Beyer A, Koch T, Schroder H, Schulz S, Hollt V (2004) Effect of the A118G polymorphism on binding affinity, potency and agonist-mediated endocytosis, desensitization, and resensitization of the human mu-opioid receptor. J Neurochem 89: 553-560.
10. Tan EC, Tan CH, Karupathivan U, Yap EP (2003) Mu opioid receptor gene polymorphisms and heroin dependence in Asian populations. Neuroreport 14(4): 569-572.
11. Klepstad P, Rakvag TT, Kaasa S et al (2004) The 118 AG polymorphism in the human micro-opioid receptor gene may increase morphine requirements in patients with pain caused by malignant disease. Acta Anaesthesiol Scand 48: 1232-1239.
12. Chou WY, Yang LC, Lu H et al (2006) Association of mu-opioid receptor gene polymorphism (A118G) with variations in morphine consumption for analgesia after total knee arthroplasty. Acta Anaesthesiol Scand 50: 787-792.
13. Fillingim RB, Kaplan L, Staud R et al (2005) The A118G single nucleotide polymorphism of the mu-opioid receptor gene (OPRM1) is associated with pressure pain sensitivity in humans. J Pain 6: 159-167.
14. OPRM1, Unigene Database. Available: www. ncbi. nlm. nih. gov/sites/entrez?db=unigene. Accessed on August 6, 2012.
15. Shabalina SA, Zaykin DV, Gris P et al (2009) Expansion of the human mu-opioid receptor gene architecture: novel functional variants. Hum Mol Gen 18(6): 1037-1051.
16. Pasternak DA, Pan L, Xu J et al (2004) Identification of three new alternatively spliced variants of the rat mu opioid receptor gene: dissociation of affinity and efficacy. J Neurochem 91: 881-890.
17. Schuller AG, King MA, Zhang J et al (1999) Retention of heroin and morphine-6 beta-glucuronide analgesia in a new line of mice lacking exon 1 of MOR-1. Nat Neurosci 2: 151-156.
18. Zhang L, Kendler KS, Chen X (2006) The mu-opioid receptor gene and smoking initiation and nicotine dependence. Behav Brain Funct 2(28): 1-6.
19. Gilbert EH, Lowenstein SR, Koziol J, Barta DC, Steiner J (1996) Chart reviews in emergency medicine research: where are the methods? Ann Emerg Med 27: 305-308.
20. Hernandez-Avila CA, Wand G, Luo X et al (2003) Association between the cortisol response to opioid blockade and the Asn40Asp polymorphism at the mu-opioid receptor locus (OPRM1). Am J Med Genet B Neuropsychiatr Genet 118B: 60-65.
21. Wand GS, McCaul M, Yang X et al (2002) The mu-opioid receptor gene polymorphism (A118G) alters HPA axis activation induced by opioid receptor blockade. Neuropsychopharmacology 26: 106-114.
22. Purcell S, Neale B, Todd-Brown K et al (2007) PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 81(3): 559-575.
23. Oslin DW, Berrettini W, Kranzler HR et al (2003) A functional polymorphism of the mu-opioid receptor gene is associated with naltrexone response in alcohol-dependent patients. Neuropsychopharmacology 28: 1546-1552.
24. Anton RF, Oroszi G, O'Malley S et al (2008) An evaluation of mu-opioid receptor (OPRM1) as a predictor of naltrexone response in the treatment of alcohol dependence. Arch Gen Psychiatry 65(2): 135-144.
25. Sora I, Takahashi N, Funada M et al (1997) Opiate receptor knockout mice define mu receptor roles in endogenous nociceptive responses and morphine-induced analgesia. Proc Natl Acad Sci 94: 1544-1549.
26. Ray LA, Barr CS, Blendy JA, Oslin D, Goldman D, Anton RF (2012) The role of the Asn40Asp polymorphism of the mu opioid receptor gene (OPRM1) on alcoholism etiology and treatment: a critical review. Alcohol Clin Exp Res 36: 385-394.
27. Proudnikov D, Randesi M, Levran O et al (2012) Association of polymorphisms of the mu opioid receptor gene with the severity of HIV infection and response to HIV treatment. J Infect Dis 205(11): 1745-1756.
28. Bortsov AV, Millikan RC, Belfer I, Boortz-Marx RL, Arora H, McLean SA (2012) μ-Opioid receptor gene A118G polymorphism predicts survival in patients with breast cancer. Anesthesiology 116(4): 896-902.
29. Arias AJ, Chan G, Gelernter J, Farrer L, Kranzler HR (2012) Variation in OPRM1 and risk of suicidal behavior in drug-dependent individuals. Am J Addict 21(1): 5-10.
30. Hishimoto A, Cui H, Mouri K et al (2008) A functional polymorphism of the micro-opioid receptor gene is associated with completed suicides. J Neural Transm 115: 531-536.
31. Tan E, Lim E, Teo Y, Lim Y, Law H, Sia A (2009) Ethnicity and OPRM variant independently predict pain perception and patient-controlled analgesia usage for post-operative pain. Mol Pain 5(32): 1-8.